Skip to content
Made In The USA Gift Guide

Made in the USA Find the perfect gifts for everyone on your list this holiday season

Advertisement

Business_Finance

Latest Stories

tv-cnn-retraction_07597.jpg

tv-cnn-retraction_07597.jpg

FILE - In this Jan. 13, 2017 file photo, Anthony Scaramucci, a senior adviser to President-elect Donald Trump, talks to reporters in the lobby of Trump Tower in New York. CNN isn't commenting Monday, June 26, as to what led it to retract a story about a supposed investigation into a pre-inaugural meeting between an associate of Trump and the head of a Russian investment fund. The story posted Thursday on CNN's website said Senate investigators are looking into the meeting between Scaramucci and Kirill Dmitriev, whose Russian Direct Investment Fund guides investments by U.S. entities in Russia. Scaramucci, in the story, said he exchanged pleasantries in a restaurant with Dmitriev. (AP Photo/Evan Vucci, File)

martin_shkreli_trial_34718.jpg

martin_shkreli_trial_34718.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

martin_shkreli_trial_80785.jpg

martin_shkreli_trial_80785.jpg

Martin Shkreli, center, the former pharmaceutical CEO who became a pariah after raising the cost of a life-saving drug 5,000 percent, is the focus of media attention as he arrives at federal court in the Brooklyn borough of New York, for jury selection in his trial. (AP Photo/Richard Drew)

martin_shkreli_trial_02674.jpg

martin_shkreli_trial_02674.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli arrives to federal court in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

martin_shkreli_trial_00244.jpg

martin_shkreli_trial_00244.jpg

Martin Shkreli, the former pharmaceutical CEO who became a pariah after raising the cost of a life-saving drug 5,000 percent, arrives at federal court in the Brooklyn borough of New York for jury selection in his trial. (AP Photo/Richard Drew)

AP_9107311889

AP_9107311889

Taikichiro Mori (1 March 1904 – 30 January 1993) was Dean of the Faculty of Commerce at Yokohama City University who later became a real estate investor at age 51. During his tenure at the University, he founded the Mori Building Company. After retiring from the University in 1959, he became the president of the company. His investments made him the richest man in the world in 1992, when he had a net worth of $13 billion.

martin_shkreli_trial_54914.jpg

martin_shkreli_trial_54914.jpg

FILE - In this Monday, June 19, 2017, file photo, former Turing Pharmaceuticals CEO Martin Shkreli, second from right, arrives at Brooklyn federal court with members of his legal team, in New York, for a pretrial conference in his securities fraud trial. Shkreli's trial begins Monday, June 26, 2017. (AP Photo/Mark Lennihan, File)

martin_shkreli_trial_28958.jpg

martin_shkreli_trial_28958.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

aptopix_martin_shkreli_trial_67039.jpg

aptopix_martin_shkreli_trial_67039.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman, in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

martin_shkreli_trial_06485.jpg

martin_shkreli_trial_06485.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

soldiers_forestry_21073.jpg

soldiers_forestry_21073.jpg

In a June 15, 2017 photo, Sally Gorrill, a captain in the U.S. Army, removes unauthorized markings from a tree along a trail in a wilderness area of the White Mountain National Forest in New Hampshire. Several soldiers looking to transition to a new career are spending the summer in the forest as part of an internship, getting training in land management skills as they prepare to transition out of the service. (Terry Asbridge via AP)

defense_spending_89925.jpg

defense_spending_89925.jpg

In this April 26, 2017, file photo House Armed Services Committee Chairman Rep. Mac Thornberry, R-Texas, speaks on Capitol Hill in Washington. (AP Photo/Manuel Balce Ceneta, File)

martin_shkreli_trial_44105.jpg

martin_shkreli_trial_44105.jpg

In this Monday, June 19, 2017, file photo, former Turing Pharmaceuticals CEO Martin Shkreli arrives at Brooklyn federal court with members of his legal team, in New York, for a pretrial conference in his securities fraud trial. Shkreli's trial begins Monday, June 26. (AP Photo/Mark Lennihan, File)

japan_takata_bankruptcy_56410.jpg

japan_takata_bankruptcy_56410.jpg

Japanese air bag maker Takata Corp. CEO Shigehisa Takada speaks during a press conference in Tokyo, Monday, June 26, 2017. Takata Corp. has filed for bankruptcy protection in Tokyo and the U.S., overwhelmed by lawsuits and recall costs related to its production of defective air bag inflators linked to the deaths of at least 16 people. (Yu Nakajima/Kyodo News via AP)

japan_takata_bankruptcy_84876.jpg

japan_takata_bankruptcy_84876.jpg

Japanese air bag maker Takata Corp. CEO Shigehisa Takada, left, arrives at a press conference in Tokyo, Monday, June 26, 2017. Japanese air bag maker Takata Corp. has filed for bankruptcy protection in Tokyo and the U.S., overwhelmed by lawsuits and recall costs related to its production of defective air bag inflators linked to the deaths of at least 16 people. (AP Photo/Shizuo Kambayashi)

aptopix_japan_takata_bankruptcy_55760.jpg

aptopix_japan_takata_bankruptcy_55760.jpg

Japanese air bag maker Takata Corp. CEO Shigehisa Takada bows during a press conference in Tokyo, Monday, June 26, 2017. Takata has filed for bankruptcy protection in Tokyo and the U.S., overwhelmed by lawsuits and recall costs related to its production of defective air bag inflators. (AP Photo/Shizuo Kambayashi)

japan_takata_bankruptcy_48696.jpg

japan_takata_bankruptcy_48696.jpg

In this May 10, 2017 photo, a visitor walks past the logo of Takata Corp. at a Toyota showroom in Tokyo. Japanese air bag maker Takata Corp. filed for bankruptcy protection in Tokyo on Monday, June 26, 2017 and the U.S., drowned in a sea of lawsuits and recall costs. (AP Photo/Shizuo Kambayashi)

takata_bankruptcy_39054.jpg

takata_bankruptcy_39054.jpg

TK Holdings Inc. headquarters is shown in Auburn Hills, Mich., Sunday, June 25, 2017. Japanese air bag maker Takata Corp. on Monday filed for bankruptcy protection, as part of a restructuring scheme to restore its business battered by a global recall of its defective air bag inflators, sources familiar with the matter said. (AP Photo/Paul Sancya)

lpga_tour_golf_75143.jpg

lpga_tour_golf_75143.jpg

So Yeon Ryu, from Korea, watches her drive on the third hole during the third round of the LPGA Wal-Mart NW Arkansas Championship golf tournament at Pinnacle Country Club in Rogers, Ark., Sunday, June 25, 2017. (AP Photo/Michael Woods)

takata-legal_claims_85604.jpg

takata-legal_claims_85604.jpg

FILE - This July 6, 2016, file photo, shows the logo of Takata Corp. at an auto supply shop in Tokyo. Drowning in a sea of lawsuits and recall costs, Japanese air bag maker Takata Corp. is expected to seek bankruptcy protection in Tokyo and the United States early Monday, June 26, 2017. (AP Photo/Shizuo Kambayashi, File)